Epitopes on the spike protein of a nephropathogenic strain of infectious bronchitis virus - PubMed (original) (raw)

Epitopes on the spike protein of a nephropathogenic strain of infectious bronchitis virus

R L Parr et al. Arch Virol. 1993.

Abstract

Infectious bronchitis virus (IBV), the first coronavirus described, was initially associated with severe respiratory disease. However, outbreaks have more recently also been associated with nephropathogenesis. Topographically interrelated antigenic determinants of the nephropathogenic Gray strain of IBV were characterized using eleven monoclonal antibodies (MAbs). Four MAbs (IgG 2a kappa) defined epitopes that were both conformation-independent and group specific, reacting with Gray, Arkansas (Ark), and Massachusetts 41 (Mass 41) strains. Seven MAbs (IgG 1 kappa) defined conformation-dependent epitopes that could differentiate the Gray from the Ark and Mass strains. The spike protein specificity of the MAbs was determined with the conformation-independent MAbs and one MAb that reacted only in "non-denaturing" western blot assays. Competitive binding studies using these MAbs suggested a high degree of functional dependency among the associated epitopes as might be expected with a protein of complex secondary and tertiary structure. At least two regions associated with complete protection of infected embryos were identified that consisted of both conformation-dependent and independent epitopes. However, a "non-neutralizing" MAb, which did not protect the embryo from gross lesions, did inhibit virus-induced lesions and replication in the kidneys. These MAbs should be valuable tools in studying IBV pathogenesis.

PubMed Disclaimer

References

    1. Cavanagh D, Davis PJ. Coronavirus IBV: removal of spike glycopolypeptide S 1 by urea abolishes infectivity and haemagglutination but not attachment to cells. J Gen Virol. 1986;67:1443–1448. - PubMed
    1. Cavanagh D, Davis PJ, Darbyshire JH, Peters RW. Coronavirus IBV: virus retaining spike glycopolypeptide S 2, but not S 1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. J Gen Virol. 1986;67:1435–1442. - PubMed
    1. Cavanagh D, Davis PJ, Mockett APA. Amino acids within hypervariable region 1 of avian coronavirus IBV (Massachusetts serotype) spike glycoprotein are associated with neutralization epitopes. Virus Res. 1988;11:141–150. - PMC - PubMed
    1. Collisson EW, Junzhou L, Sneed LW, Peters ML, Wang L. Detection of avian infectious bronchitis viral infection using in situ hybridization and recombinant DNA. Vet Microbiol. 1990;24:261–271. - PMC - PubMed
    1. Collisson EW, Parr RL, Wang L, Williams A. An overview of the molecular characteristics of avian infectious bronchitis virus. Poultry Sci Rev. 1992;4:41–55.

Publication types

MeSH terms

Substances

LinkOut - more resources